Programmed death-1 (PD-1) and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma.

被引：0
|
作者：
Paydas, Semra
Bagir, Emine
Ergin, Melek
Duman, Berna Bozkurt
Ercolak, Vehbi
机构：
[1] Cukurova Univ, Fac Med, Adana, Turkey
[2] Cukurova Univ, Adana, Turkey
[3] Cukurova Univ, Fac Med, Dept Pathol, Adana, Turkey
[4] Adana Numune Educ & Res Hosp, Adana, Turkey
[5] Cukurova Univ, Sch Med, Dept Med Oncol, Adana, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e19514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19514
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma
    Paydas, Semra
    Bagir, Emine
    Seydaoglu, Gulsah
    Ercolak, Vehbi
    Ergin, Melek
    ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1545 - 1552
  • [2] Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma
    Semra Paydas
    Emine Bağır
    Gulsah Seydaoglu
    Vehbi Ercolak
    Melek Ergin
    Annals of Hematology, 2015, 94 : 1545 - 1552
  • [3] Programmed death-1 (PD-1) Expression in Sezary Syndrome
    Wehkamp, U.
    Oschlies, I
    Brasch, J.
    Klapper, W.
    Weichenthal, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 922 - 922
  • [4] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1125 - 1125
  • [5] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 219 - 219
  • [6] Expression of programmed death-1 (PD-1) and its ligands in Sezary syndrome
    Saulite, Ieva
    Ignatova, Desislava
    Chang, Yun-Tsan
    Fassnacht, Christina
    Varypataki, Eleni
    Anzengruber, Florian
    Nageli, Mirjam
    Cozzio, Antonio
    Dummer, Reinhard
    Scarisbrick, Julia
    Pascolo, Steve
    Hoetzenecker, Wolfram
    Bobrowicz, Malgorzata
    Guenova, Emmanuella
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S13 - S13
  • [7] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    LABORATORY INVESTIGATION, 2017, 97 : 344A - 344A
  • [8] Programmed Death-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Expression in Aggressive Pediatric Lymphomas
    Coffey, Amy M.
    Curry, Jonathan L.
    Marcogliese, Andrea N.
    Tetzlaff, Michael T.
    Kamdar, Kala
    Elghetany, Mohamed T.
    Curry, Choladda V.
    MODERN PATHOLOGY, 2017, 30 : 344A - 344A
  • [9] Expression of programmed death-1 (PD-1) in sentinel lymph nodes of breast cancer
    Mukohara, Toru
    Tatara, Takashi
    Shimono, Yohei
    Yamasaki, Takashi
    Toyoda, Masanori
    Kiyota, Naomi
    Takao, Shintaro
    Kono, Seishi
    Kakeji, Yoshihiro
    Minami, Hironobu
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma
    Lee, Joycelyn J. X.
    Chan, Alexandre
    Tang, Tiffany
    ACTA ONCOLOGICA, 2016, 55 (04) : 519 - 520
12345